Trial intelligence / Profile preview

Inhaled Nitric Oxide After Out-of-Hospital Cardiac Arrest

NCT03079102Phase 2Terminated

Start
Aug 2017
Primary completion
May 2020
Modality
DNA Intercalators/Alkylators, Inhalation Devices
Countries
1
01

Overview

A Phase 2 trial of nitric oxide in cardiac arrest (SCA). Started Aug 2017; status: terminated.

02

Drugs

nitric oxide
03

Conditions

cardiac arrest (SCA)

Beyond the preview

Go deeper on NCT03079102.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03079102.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call